If I'm not mistaken, the Q1 shows the $155k as future revenues and not yet collected. We can still count that though. Here's the thing, $4M to keep this exclusive doesn't mean $4M in revenue. If the product isn't selling, then $155k is where that revenue stream ends.
As for the multiple F500 deals and $20M that has been thrown around, it would be nice to see something come of that.
There are no patents that are co-owned that I can see. Granted applications and pending patents can take many months to be published, but it's been many months since a PR saying that products developed will share IP rights.
I still maintain that anyone here should be cautious going forward because of the nature of the company structure. HCTI, NTI, and Nanotech are tangled together in a way that common shareholders could easily be left holding the bill while another branch that is privately held reaps all of the benefits. A quick google search of Kristul reveals several previous business dealings where investors felt they were severely misled and ultimately lost their loans or investments depending on how you want to look at it.
Also, what has Kristul's German company done to earn the money that HCTI has been sending their way?
Is this a cash cow for the investors here or for Kristul and a few of his business partners? I can't be sure, and don't want to risk it.
